Clinical Trial Update: Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp [Phase 2]

View source ↗

Summary

Phase 2 trial update for KX2-391 ointment in actinic keratosis on face/scalp; study completed with posted results in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• KX2-391 ointment (KX2-391)

Snippet

Sponsor: Almirall, S.A. | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-14